Loading…
Disc Medicine, Inc. is projected to rise to $91.58 by 2027, a +31% move from its current price of $69.76. IRON is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $68.47 | $69.78 | $71.11 | +0.03% |
| May 30 | $67.95 | $69.80 | $71.69 | +0.05% |
| May 31 | $67.56 | $69.81 | $72.14 | +0.08% |
| Jun 1 | $67.24 | $69.83 | $72.53 | +0.10% |
| Jun 2 | $66.95 | $69.85 | $72.87 | +0.13% |
| Jun 3 | $66.70 | $69.87 | $73.19 | +0.16% |
| Jun 4 | $66.47 | $69.89 | $73.48 | +0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $66.47 | $69.89 | $73.48 | +0.18% |
| Week 2 | $65.22 | $70.01 | $75.16 | +0.36% |
| Week 3 | $64.31 | $70.14 | $76.51 | +0.55% |
| Week 4 | $63.56 | $70.27 | $77.68 | +0.73% |
| Week 5 | $62.93 | $70.40 | $78.75 | +0.91% |
| Week 6 | $62.37 | $70.53 | $79.74 | +1.10% |
| Week 7 | $61.88 | $70.65 | $80.68 | +1.28% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company that, together with its subsidiaries, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis.
Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.
Disc Medicine, Inc. (IRON) is a Healthcare stock with a current price of $66.82 and a market cap of $2.55B, ranking 1842 by market capitalization. The stock faces a near-term landscape that is shaped by a structured forecast of future prices, including a neutral near term and a bullish longer-term trajectory.
In 2026, the expected average price is $66.82 with a min of $55.95 and a max of $93.78, and a 0% ROI, reflecting neutral sentiment.
From 2027 onward, the forecast shows a bullish path with higher average prices and meaningful upside potential, culminating in a 2050 max of $1,233.58 and a 1022% ROI on the highest end of the forecast. The 2027 average is $84.36, 2028 is $107.43, and 2029 is $129.90, illustrating a continued upward trajectory across the next several years.
A major floor 19.8% below — a decisive break under it would weaken the trend.
The nearest floor, 8.2% below — buyers have tended to step in here.
Price is pressing into resistance (2.9% away) — a breakout level to watch.
A major ceiling 17.7% above — clearing it would confirm fresh momentum.
Key IRON support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IRON market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $67.77 | Buy | $68.11 | Buy |
| MA 10 | $67.64 | Buy | $67.80 | Buy |
| MA 20 | $67.63 | Buy | $67.71 | Buy |
| MA 50 | $66.27 | Buy | $67.66 | Buy |
| MA 100 | $68.82 | Buy | $68.98 | Buy |
| MA 200 | $72.40 | Sell | $68.53 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.05 | Neutral |
| Stoch RSI (14) | 92.01 | Sell |
| CCI (20) | 126.28 | Buy |
| Williams %R (14) | -4.53 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 2.20 | Buy |
| Bollinger %B (20,2) | 0.87 | Neutral |
| Stochastic %K (14) | 95.47 | Sell |
| TRIX (15) | 0.04 | Buy |
| Awesome (5,34) | -0.47 | Sell |
| Ultimate (7,14,28) | 60.09 | Neutral |
| Momentum (10) | 1.23 | Buy |
| Aroon Osc (25) | -16.00 | Sell |
| Hull MA (9) | 68.32 | Buy |
| ADX (14) | 9.84 | Neutral |
| ATR (14) | 1.18 | Info |
Technical picture for the last 30 days shows a Neutral sentiment with RSI(14) at 50. The stock trades around the 50-day moving average of $65.93 and below the 200-day moving average of $72.29. Near-term support is at $64.07 and resistance at $71.77, with a 30-day price range from $58.88 to $75.83. Annualized volatility stands at 40%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $55.95 | $69.76 | $99.24 | 0% | Neutral | |
| $74.79 | $91.58 | $117.41 | +31% | Bullish | |
| $94.37 | $117.68 | $154.83 | +69% | Bullish | |
| $114.22 | $144.61 | $194.23 | +107% | Bullish | |
| $117.76 | $151.09 | $206.56 | +117% | Bullish | |
| $129.61 | $168.31 | $233.70 | +141% | Bullish | |
| $142.22 | $186.77 | $262.99 | +168% | Bullish | |
| $149.68 | $198.64 | $283.30 | +185% | Bullish | |
| $175.79 | $235.61 | $340.02 | +238% | Bullish | |
| $202.52 | $274.00 | $399.83 | +293% | Bullish | |
| $277.30 | $391.36 | $598.40 | +461% | Bullish | |
| $627.38 | $949.96 | $1,557.02 | +12.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $55.95 | $69.76 | $81.70 | +0.00% |
| June 2026 | $59.81 | $69.77 | $82.99 | +0.02% |
| July 2026 | $60.88 | $71.43 | $85.77 | +2.38% |
| August 2026 | $63.81 | $75.22 | $90.97 | +5.30% |
| September 2026 | $64.84 | $76.71 | $93.34 | +1.99% |
| October 2026 | $64.56 | $76.64 | $93.75 | -0.09% |
| November 2026 | $65.97 | $78.56 | $96.56 | +2.50% |
| December 2026 | $67.31 | $80.38 | $99.24 | +2.32% |
Click any year to see its month-by-month IRON forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect IRON to range from $55.95 to $99.24 through 2026. The $69.76 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The IRON price prediction for 2027 points to an average of $91.58 (low $74.79, high $117.41) — a potential gain of +31% on today's $69.76. Momentum favours further upside here.
In 2028, IRON is projected to trade between $94.37 and $154.83, averaging $117.68 — a potential gain of +69% from today's $69.76. That is up +28% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Disc Medicine, Inc.'s 2029 outlook centres on $144.61, within a $114.22 to $194.23 range. That is up +23% on the projected 2028 average. That marks a +107% change versus current levels. Momentum favours further upside here.
By 2030, IRON could reach as high as $206.56, with a base case around $151.09 and support toward $117.76 — roughly +117% from $69.76. Buyers look set to stay in control over this stretch.
Expect IRON to range from $129.61 to $233.70 through 2031. The $168.31 average target implies a +141% move from current prices. That is up +11% on the projected 2030 average. Momentum favours further upside here.
The IRON price prediction for 2032 points to an average of $186.77 (low $142.22, high $262.99) — a potential gain of +168% on today's $69.76. Buyers look set to stay in control over this stretch.
In 2033, IRON is projected to trade between $149.68 and $283.30, averaging $198.64 — a potential gain of +185% from today's $69.76. That is up +6% on the projected 2032 average. Momentum favours further upside here.
Disc Medicine, Inc.'s 2034 outlook centres on $235.61, within a $175.79 to $340.02 range. That is up +19% on the projected 2033 average. That marks a +238% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, IRON could reach as high as $399.83, with a base case around $274.00 and support toward $202.52 — roughly +293% from $69.76. Momentum favours further upside here.
Expect IRON to range from $277.30 to $598.40 through 2040. The $391.36 average target implies a +461% move from current prices. That is up +43% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The IRON price prediction for 2050 points to an average of $949.96 (low $627.38, high $1,557.02) — a potential gain of +12.6x on today's $69.76. Momentum favours further upside here.
Investing $1,000 in IRON today (≈ 14.334862 IRON) could be worth
$13,617.6
+$12,617.6 (+1262%) by 2050 · US Dollar
Based on the average projected IRON price of $949.96 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IRONwould be worth at today's price.
$1,000 invested in IRON on May 27, 2025 (≈ 21.795989 IRON) would be worth
$1,520.49
+$520.49 (+52.0%) today · 1.52× · US Dollar
Based on a IRON entry price of $45.88 vs. today's $69.76.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $67.03 | $1,040.73 | +4.1% |
| 1 month ago | $68.85 | $1,013.22 | +1.3% |
| 3 months ago | $67.91 | $1,027.24 | +2.7% |
| 6 months ago | $93.36 | $747.22 | -25.3% |
| 1 year ago | $45.88 | $1,520.49 | +52.0% |
| All time (5.0y) ago | $387 | $180.26 | -82.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IRON forecast.
Our base-case forecast reaches $140.00 around 2029.
Implied market cap at $140.00: $5.35B
Looking further out, the multi-year forecast paints a bullish portrait with rising averages and strong upside potential. The 2030 average is $133.55 with a min of $103.91 and a max of $182.97, yielding a 99.9% ROI and a bullish sentiment. The 2040 forecast shows an average of $321.28, a min of $226.94, a max of $492.85, and an 380.8% ROI, maintaining a bullish outlook.
The 2050 forecast is the most expansive, with an average of $749.72, a min of $493.04, a max of $1,233.58, and a 1022% ROI, all under a bullish sentiment. These figures imply substantial upside in the long horizon, but they are estimates and not guarantees. Risks include market variability and the inherent uncertainty of clinical-stage biotechnology outcomes, which could influence actual performance versus these projections.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $133.55 with a min of $103.91 and a max of $182.97, and a 99.9% ROI, with bullish sentiment.
The forecast portrays a bullish path from 2027 through 2050, with rising averages and notable upside (e.g., 2027 avg $84.36; 2040 avg $321.28; 2050 avg $749.72 and max $1,233.58). However, the near-term 2026 avg is $66.82 with 0% ROI and neutral sentiment, and these are estimates, not guarantees.
Yes. The 2050 max forecast is $1,233.58, indicating a possible exceedance of $1,000 in the long horizon.
The 30-day range is $58.88 to $75.83.
Current price is $66.82 and market cap is $2.55B.
Disc Medicine, Inc. Community Discussion
0Share your Disc Medicine, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.